FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
- Posted on May 28, 2026
- By The Independent
- 0 Views
- 1 min read
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
